Therapeutic Advances in Neurological Disorders (Feb 2021)

Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment

Navid Manouchehri,
Olaf Stüve

Affiliations

Navid Manouchehri
Olaf Stüve

DOI: https://doi.org/10.1177/1756286421990500
Journal volume & issue: Vol. 14

Abstract

No abstracts available.

Published in Therapeutic Advances in Neurological Disorders

ISSN: 1756-2856 (Print); 1756-2864 (Online)
Publisher: SAGE Publishing
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
Website: https://journals.sagepub.com/home/tan

About the journal